Seeing Is Believing
Currently out of the existing stock ratings of Trevor Allred, 15 are a BUY (100%).
Analyst Trevor Allred, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 66.67% that have a potential upside of 27.3% achieved within 97 days.
Trevor Allred’s has documented 30 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on INVA, Innoviva at 23-Sep-2026.
Analyst best performing recommendations are on DNTH (DIANTHUS THERAPEUTICS).
The best stock recommendation documented was for DNTH (DIANTHUS THERAPEUTICS) at 11/6/2025. The price target of $62 was fulfilled within 118 days with a profit of $25.57 (70.19%) receiving and performance score of 5.95.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-May-2021
$156
$90.65 (138.71%)
$157
Buy Since 13-Apr-2020
$120
$54.65 (83.63%)
$120
1 months 2 days ago
(10-Sep-2026)
35/43 (81.4%)
$47.5 (65.52%)
348
Buy Since 18-Feb-2020
$110
$44.65 (68.32%)
$96
1 months 11 days ago
(01-Sep-2026)
29/36 (80.56%)
$33.43 (43.66%)
524
Buy Since 22-Jul-2019
$111
$45.65 (69.85%)
$94
2 months ago
(12-Aug-2026)
18/20 (90%)
$27.16 (32.40%)
210
Buy Since 03-Jun-2026
$106
$40.65 (62.20%)
$104
2 months ago
(12-Aug-2026)
0/2 (0%)
$22.16 (26.43%)
Which stock is Trevor Allred most bullish on?
What Year was the first public recommendation made by Trevor Allred?